1184PDResults of a phase I trial with MART-1 T cell receptor modified T cells in patients with metastatic melanoma
Rohaan, M W, Gomez-Eerland, R, Foppen, M H Geukes, van Zon, M, de Boer, R, Bakker, N A M, Pronk, L M, Sari, A, Mallo, H A, van de Wiel, B A, Lalezari, F, Beijnen, J H, Nuijen, B, van Tinteren, H, van Thienen, J V, Blank, C U, Wilgenhof, S, Schumacher, T N, van den Berg, J H, Haanen, J B A G
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article